Leading Edge Medical Treatments Slavin and Weber to Present at ISLA Congress
Two members of the Leading Edge Medical Treatments Science Advisory Board are scheduled to give lectures at the forthcoming ISLA Congress.
Hong Kong – LEMed (Leading Edge Medical Treatments, Ltd.) the specialist stem cell and medical laser therapy research and distribution group has announced that two members of its Science Advisory Board have been scheduled to give lectures to attendees and delegates at the forthcoming 9th International Congress on Medical Laser Applications to be held in Beverungen, Germany from June 27th to 29th.
Dr. Michael Weber, founder at Germany’s Weber Medical and a president of ISLA (International Society for Medical Laser Applications) and Israel’s Dr. Shimon Slavin, a stem cell treatment pioneer are both looking forward to discussing their ideas with like-minded innovators and practitioners within the medical laser arena.
Dr. Slavin said, “One of the reasons I agreed to take up a position on the Leading Edge Medical Treatments Science Advisory Board was the company’s keen interest in the development of combination therapy. Their advocacy of adult stem cells and the lengths they were prepared to go to in order to secure the laser therapy expertise of Dr. Weber, my colleague on the Advisory Board, was crucial.
Dr. Weber added, “While with LEMed Dr. Slavin has developed a keen interest in unlocking the potential of medical lasers in terms of developing fast-acting stem cell treatments and has become particularly well informed in a remarkably short period of time. He will provide some incredible insight into what I think are ground-breaking theories that will likely thrill attendees”
Dr. Weber is scheduled to give his presentations on Saturday 28th June 2014 at 12.10 on Clinical applications of photodynamic tumor therapy while Dr. Slavin will address delegates on the same day at 15.20 on the use of multi-potent mesenchymal stromal cells for regenerative medicine, which he has refined whilst at LEMed.
Leading Edge Medical Treatments, Ltd. is based in Hong Kong. ISIN: HK0000185196
About Leading Edge Medical Treatments, Ltd.
Cellular medicine is revolutionizing medical treatment in the 21st century and LEMed’s treatments are at the forefront of the field. Thousands of patients around the world have already benefited from bio-technologies using stem cells and/or intravenous laser therapy. Diseases once considered incurable are responding well to stem cell therapies and are restoring a quality of life to patients they thought they had lost forever.
LEMed is committed to applying modern day best practices to the growing field of regenerative medicine. With advanced medical treatment facilities offering personalized, ongoing care plans and the highest quality of customer service, we are dedicated to providing a better life for patients.
For more information contact:
Client Services Director: Jeffery Tobin
Leading Edge Medical Treatments, Ltd.
14F, 8 Hennessy Road,
China Hong Kong Tower,
Wan Chai 999077
Hong Kong
+85221270684
info@healingmed.com
http://www.healingmed.com